Peter Altevogt
#159,462
Most Influential Person Now
Researcher
Peter Altevogt's AcademicInfluence.com Rankings
Peter Altevogtcomputer-science Degrees
Computer Science
#9036
World Rank
#9495
Historical Rank
Machine Learning
#3858
World Rank
#3904
Historical Rank
Artificial Intelligence
#4185
World Rank
#4243
Historical Rank
Database
#6032
World Rank
#6255
Historical Rank
Download Badge
Computer Science
Peter Altevogt's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Peter Altevogt Influential?
(Suggest an Edit or Addition)Peter Altevogt's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation (2012) (1104)
- Exosomes: from biogenesis and secretion to biological function. (2006) (839)
- Body fluid derived exosomes as a novel template for clinical diagnostics (2011) (586)
- Interaction and uptake of exosomes by ovarian cancer cells (2011) (527)
- Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins (2001) (405)
- Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression (2018) (377)
- L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers (2005) (373)
- CD24 is a marker of exosomes secreted into urine and amniotic fluid. (2007) (338)
- Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors (2018) (330)
- CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. (1997) (326)
- Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression (2018) (325)
- Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. (2007) (322)
- CD24 mediates rolling of breast carcinoma cells on P‐selectin (1998) (304)
- CD24 expression is a new prognostic marker in breast cancer. (2003) (302)
- Tumour Biological Aspects of CD24, A Mucin-Like Adhesion Molecule (2003) (299)
- Extracellular Vesicle-Mediated Transfer of Genetic Information between the Hematopoietic System and the Brain in Response to Inflammation (2014) (299)
- L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas (2003) (287)
- The neural cell adhesion molecule N-CAM enhances L1-dependent cell-cell interactions (1990) (280)
- Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. (2009) (272)
- A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. (2006) (252)
- Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage. (2011) (246)
- Sulforaphane targets pancreatic tumour-initiating cells by NF-κB-induced antiapoptotic signalling (2008) (233)
- ADAM10‐mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles (2003) (230)
- L1 Is Sequentially Processed by Two Differently Activated Metalloproteases and Presenilin/γ-Secretase and Regulates Neural Cell Adhesion, Cell Migration, and Neurite Outgrowth (2005) (226)
- Integrin Leukocyte Function-associated Antigen-1-mediated Cell Binding Can Be Activated by Clustering of Membrane Rafts* (1999) (209)
- Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment (2015) (205)
- Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis (2007) (203)
- Body Fluid Exosomes Promote Secretion of Inflammatory Cytokines in Monocytic Cells via Toll-like Receptor Signaling* (2013) (202)
- L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation. (2013) (195)
- Role of Src Kinases in the ADAM-mediated Release of L1 Adhesion Molecule from Human Tumor Cells* (2000) (191)
- CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells (2006) (190)
- Cleavage of L1 in Exosomes and Apoptotic Membrane Vesicles Released from Ovarian Carcinoma Cells (2005) (185)
- Functional cooperation between the neural adhesion molecules L1 and N- CAM is carbohydrate dependent (1990) (174)
- The L1 adhesion molecule is a cellular ligand for VLA-5 (1995) (161)
- Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. (2006) (158)
- Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma (2018) (157)
- Cytoplasmic CD24 Expression in Colorectal Cancer Independently Correlates with Shortened Patient Survival (2005) (156)
- Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation (1983) (156)
- Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. (1983) (154)
- Tumor Cell Invasion Is Promoted by Activation of Protease Activated Receptor-1 in Cooperation with the αvβ5 Integrin* (2001) (151)
- Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30. (2014) (151)
- SOX2 in development and cancer biology. (2020) (145)
- The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. (2000) (144)
- L1CAM: a major driver for tumor cell invasion and motility. (2012) (140)
- Association of CD2 and CD45 on human T lymphocytes (1990) (137)
- Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. (2008) (137)
- L1CAM malfunction in the nervous system and human carcinomas (2010) (130)
- Heat-stable antigen (CD24) as ligand for mouse P-selectin. (1994) (126)
- L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma. (2003) (120)
- L1CAM in human cancer (2016) (120)
- Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells (2007) (118)
- Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model. (2007) (116)
- Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease‐dependent ectodomain shedding and exosome secretion (2008) (111)
- Up‐regulation of L1CAM is linked to loss of hormone receptors and E‐cadherin in aggressive subtypes of endometrial carcinomas (2010) (111)
- CD24 is a marker for human breast carcinoma. (1999) (109)
- L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to αvβ3 integrin (1996) (108)
- CCR5+ Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions. (2018) (108)
- Heat stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin. (1995) (106)
- Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors. (2004) (102)
- The adhesion molecule L1 (CD171) promotes melanoma progression (2006) (99)
- L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. (2007) (98)
- Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. (2009) (98)
- Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/γ-secretase activity (2009) (96)
- Metalloproteinase-mediated release of the ectodomain of L1 adhesion molecule. (1999) (93)
- Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. (2009) (93)
- Anti-CD2 antibodies induce T cell unresponsiveness in vivo (1991) (92)
- Nectadrin, the heat-stable antigen, is a cell adhesion molecule (1992) (91)
- IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. (2020) (91)
- Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme. (2008) (89)
- ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. (2010) (89)
- Heat‐stable antigen/CD24 on mouse T lymphocytes: evidence for a costimulatory function (1994) (89)
- Brain development in mice lacking L1–L1 homophilic adhesion (2004) (89)
- The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies (2007) (88)
- L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer (2011) (87)
- Integrin and Neurocan Binding to L1 Involves Distinct Ig Domains* (1999) (86)
- Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors (2007) (84)
- Copper-67 Radioimmunotherapy and Growth Inhibition by Anti–L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis (2007) (82)
- Redirected T cells that target pancreatic adenocarcinoma antigens eliminate tumors and metastases in mice. (2012) (80)
- Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy. (2006) (79)
- The alpha 4 integrin chain is a ligand for alpha 4 beta 7 and alpha 4 beta 1 (1995) (77)
- Evidence for Cis Interaction and Cooperative Signalling by the Heat‐stable Antigen Nectadrin (murine CD24) and the Cell Adhesion Molecule L1 in Neurons (1995) (76)
- EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation. (2012) (76)
- CD24 induces localization of β1 integrin to lipid raft domains (2008) (72)
- L1 augments cell migration and tumor growth but not β3 integrin expression in ovarian carcinomas (2005) (72)
- Expression and function of the neural cell adhesion molecule L1 in mouse leukocytes (1992) (70)
- Contractile Forces Contribute to Increased Glycosylphosphatidylinositol-anchored Receptor CD24-facilitated Cancer Cell Invasion* (2011) (70)
- Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma. (2010) (69)
- Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation. (2012) (69)
- Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma (2014) (68)
- Long‐term Maintenance of HLA‐D Restricted T Cells Specific for Soluble Antigens (1980) (68)
- Novel insights into the function of CD24: A driving force in cancer (2020) (67)
- Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis (2010) (66)
- The cell adhesion molecule L1: species- and cell-type-dependent multiple binding mechanisms. (1997) (66)
- N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin. (2011) (66)
- Heat-stable antigen (mouse CD24) in the brain: dual but distinct interaction with P-selectin and L1. (1997) (64)
- Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation. (2014) (64)
- Myeloid-derived suppressor cells and tumor escape from immune surveillance (2017) (64)
- Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer (2016) (64)
- L1CAM–integrin interaction induces constitutive NF-κB activation in pancreatic adenocarcinoma cells by enhancing IL-1β expression (2010) (64)
- Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer (2017) (64)
- CD24 controls Src/STAT3 activity in human tumors (2012) (61)
- Extracellular Vesicles from Ovarian Carcinoma Cells Display Specific Glycosignatures (2015) (59)
- Mouse CD24 as a signaling molecule for integrin-mediated cell binding: functional and physical association with src-kinases. (1997) (59)
- Different expression levels of alpha3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell lines. (2006) (57)
- Exosomes as a potential tool for a specific delivery of functional molecules. (2013) (57)
- L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin. (1996) (57)
- CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion (2011) (56)
- Helper and suppressor-inducer activity of human T cells and their cloned progeny maintained in long-term culture. (1981) (56)
- CD24 induces localization of beta1 integrin to lipid raft domains. (2008) (55)
- Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma. (2012) (55)
- Linking L1CAM-mediated signaling to NF-κB activation. (2011) (54)
- Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney. (2008) (54)
- Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant (1982) (52)
- Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas. (2006) (51)
- Targeting SOX2 in anticancer therapy (2018) (51)
- Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas (2013) (51)
- Adhesion molecules CD171 (L1CAM) and CD24 are expressed by primary neuroendocrine carcinomas of the skin (Merkel cell carcinomas) (2003) (50)
- SOX2‐mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma (2018) (50)
- Melanoma extracellular vesicles generate immunosuppressive myeloid cells by PD-L1 upregulation via TLR4 signaling. (2019) (49)
- L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells. (2006) (49)
- Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinoma. (2009) (48)
- Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT (2015) (47)
- Antibody 12‐15 cross‐reacts with mouse Feγ receptors and CD2: study of thymus expression, genetic polymorphism and biosynthesis of the CD2 protein (1989) (46)
- Characterization of the L1-Neurocan-binding Site (2000) (46)
- Expression and prognostic value of L1-CAM in breast cancer. (2009) (46)
- Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors (2004) (45)
- Blockade of natural killer cell‐mediated lysis by NCAM140 expressed on tumor cells (2007) (44)
- CD 24 Expression Is a New Prognostic Marker in Breast Cancer (2003) (44)
- L1 adhesion molecule on mouse leukocytes: regulation and involvement in endothelial cell binding (1993) (43)
- IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma (2020) (42)
- A mouse hepatocyte carbohydrate‐specific receptor and its interaction with liver‐metastasizing tumor cells (1983) (42)
- miR-21-3p is a positive regulator of L1CAM in several human carcinomas. (2014) (42)
- TGF-β1-dependent L1CAM expression has an essential role in macrophage-induced apoptosis resistance and cell migration of human intestinal epithelial cells (2013) (41)
- Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer (2014) (41)
- Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer (2011) (41)
- Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration (2008) (41)
- A rapid method for the isolation of metastasizing tumour cells from internal organs with the help of isopycnic density-gradient centrifugation in Percoll. (1981) (41)
- Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells. (2010) (40)
- Molecular mechanisms of L-selectin-induced co-localization rafts and shedding (2003) (39)
- L1 cell adhesion molecule (L1CAM) as a pathogenetic factor in endometriosis. (2008) (39)
- E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer. (2010) (38)
- L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions (2010) (38)
- L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma (2016) (38)
- alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma. (2009) (38)
- The RGD integrin binding site in human L1-CAM is important for nuclear signaling. (2008) (37)
- Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases. (2007) (37)
- The L1 Adhesion Molecule Supports αvβ3-Mediated Migration of Human Tumor Cells and Activated T Lymphocytes (1997) (36)
- Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma. (2010) (35)
- Antigenic variation in cancer metastasis: immune escape versus immune control (2004) (32)
- Disrupted Schwann cell–axon interactions in peripheral nerves of mice with altered L1-integrin interactions (2005) (32)
- Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer (2012) (31)
- Transfer of T Cell Surface Molecules to Dendritic Cells upon CD4+ T Cell Priming Involves Two Distinct Mechanisms1 (2008) (31)
- Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal–maternal interface (2017) (31)
- Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo. (1991) (31)
- ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases (2010) (30)
- Antibodies directed against L1-CAM synergize with Genistein in inhibiting growth and survival pathways in SKOV3ip human ovarian cancer cells. (2008) (30)
- L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor (2014) (30)
- L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression (2014) (30)
- Identical forms of the CD2 antigen expressed by mouse T and B lymphocytes (1989) (29)
- L1CAM (2012) (27)
- Biochemical comparison of HLA‐DR molecules derived from autologous human T and B lymphoblasts (1980) (27)
- A role for the VLA‐4 integrin in the activation of human memory B cells (1997) (27)
- L1 Makes Immunological Progress by Expanding Its Relations (1998) (26)
- Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma (2020) (25)
- Differential, LFA-1-sensitive effects of antibodies to nectadrin, the heat-stable antigen, on B lymphoblast aggregation and signal transduction. (1994) (25)
- Structural basis for altered soybean agglutinin lectin binding between a murine metastatic lymphoma and an adhesive low malignant variant. (1987) (25)
- Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma. (2019) (23)
- Expression of L1 cell adhesion molecule is associated with lymphoma growth and metastasis (1993) (23)
- N-glycosylation patterns of HSA/CD24 from different cell lines and brain homogenates: a comparison. (2003) (23)
- Role of L1 cell adhesion molecule (L1CAM) in the metastatic cascade: promotion of dissemination, colonization, and metastatic growth (2013) (22)
- TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells (2017) (22)
- CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer (2012) (21)
- Association of CD2 and T200 (CD45) in mouse T lymphocytes. (1990) (21)
- New antigens presented on tumor cells can cause immune rejection without influencing the frequency of tumor-specific cytolytic T cells. (1987) (20)
- Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells. (1984) (20)
- Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles (2020) (20)
- Influence of L1-CAM expression of breast cancer cells on adhesion to endothelial cells (2012) (20)
- The effects of anti‐CD2 antibodies on the differentiation of mouse thymocytes (1989) (20)
- Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent. (2012) (19)
- Microenvironment and Immunology Metalloprotease-Mediated Tumor Cell Shedding of B 7-H 6 , the Ligand of the Natural Killer Cell – Activating Receptor NKp 30 (2014) (19)
- CD24 polymorphisms in breast cancer: impact on prognosis and risk (2013) (19)
- Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens (2013) (18)
- Full-Length L1CAM and Not Its Δ2Δ27 Splice Variant Promotes Metastasis through Induction of Gelatinase Expression (2011) (18)
- Single-Molecule Localization Microscopy allows for the analysis of cancer metastasis-specific miRNA distribution on the nanoscale (2015) (17)
- Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. III. Postoperative activation of tumor-specific CTLP from mice with metastases requires stimulation with the specific antigen plus additional signals. (1989) (17)
- L1 (CD171) as a novel biomarker for ovarian and endometrial carcinomas (2004) (17)
- Procoagulant extracellular vesicles in amniotic fluid (2017) (16)
- Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets (2018) (16)
- Molecular mechanisms of L-selectin-induced co-localization in rafts and shedding [corrected]. (2003) (16)
- Targeting CD 24 for Treatment of Colorectal and Pancreatic Cancer by Monoclonal Antibodies or Small Interfering RNA (2008) (15)
- Adhesive Hierarchy of the Cell Adhesion Molecules L1, CD24, and α6 Integrin in Murine Neuroblastoma N2A Cells (1995) (15)
- Mesothelial Cells in Suspension Expose an Enriched Integrin Repertoire Capable of Capturing Soluble Fibronectin and Laminin (2002) (14)
- Immunoresistant metastatic tumor variants can re‐express their tumor antigen after treatment with DNA methylation‐inhibiting agents (1986) (14)
- Effects of mutagens on the immunogenicity of tumor cells: comparison of cell surface changes induced by 5-azacytidine and N-methyl-N'-nitro-N-nitrosoguanidine. (1986) (14)
- Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression (2021) (14)
- Expression and prognostic value of L1-CAM in breast cancer (2009) (14)
- A VH‐Associated Idiotype in Human Anti‐Tetanus Antibodies (1983) (13)
- A novel method for measuring cellular antibody uptake using imaging flow cytometry reveals distinct uptake rates for two different monoclonal antibodies targeting L1. (2015) (13)
- Membranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients (2015) (13)
- Adhesive function of newcastle-disease virus hemagglutinin in tumor-host interaction. (1995) (13)
- Effects of mutagens on the immunogenicity of murine tumor cells: immunological and biochemical evidence for altered cell surface antigens. (1985) (13)
- The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women. (2008) (11)
- Inhibition of cell proliferation, adhesion, and invasion with an anti-L1-cell adhesion molecule monoclonal antibody in an in vitro endometriosis model. (2010) (11)
- Disrupted Schwann cell-axon interactions in peripheral nerves of mice with altered L1-integrin interactions. (2005) (11)
- Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions (2014) (11)
- Murine Fcγ receptor proteins: identification of a previously unrecognized molecule with a monoclonal antibody (12‐15) (1988) (11)
- The L1 adhesion molecule supports alpha v beta 3-mediated migration of human tumor cells and activated T lymphocytes. (1997) (11)
- Asp-698 and Asp-811 of the Integrin α4-Subunit Are Critical for the Formation of a Functional Heterodimer* (1998) (11)
- L1 Cell Adhesion Molecule as a Potential Therapeutic Target in Murine Models of Endometriosis Using a Monoclonal Antibody Approach (2013) (11)
- CD2: a functional adhesion molecule on murine B cells, involved in interleukin‐4‐induced aggregation (1993) (11)
- Evaluating L1CAM expression in human endometrial cancer using qRT-PCR (2016) (10)
- A Standardized Staining Protocol for L1CAM on Formalin-Fixed, Paraffin-Embedded Tissues Using Automated Platforms (2014) (10)
- L1CAM in the Early Enteric and Urogenital System (2017) (10)
- Adhesive hierarchy involving the cell adhesion molecules L1, CD24, and alpha 6 integrin in murine neuroblastoma N2A cells. (1995) (10)
- Critical amino acid residues of the α4 subunit for α4β7 integrin function (2001) (9)
- New plasma membrane proteins expressed by a high metastatic variant of a chemically induced tumor. (1984) (9)
- Glycoconjugate expression in adenoid cystic carcinoma of the salivary glands: up‐regulation of L1 predicts fatal prognosis (2011) (9)
- Tumor promoting capacity of polymorphonuclear myeloid‐derived suppressor cells and their neutralization (2021) (9)
- Fallopian tube precursor lesions of serous ovarian carcinoma require L1CAM for dissemination and metastasis (2018) (8)
- Concanavalin A-induced interferon gamma production by murine spleen cells and T cell lines. Lack of correlation with Lyt 1,2 phenotype. (1984) (8)
- Spontaneous Phenotypic Shifts from Low to High Metastatic Capacity (1983) (7)
- Membranal Cholesterol Is Not Required for L-Selectin Adhesiveness in Primary Lymphocytes but Controls a Chemokine-Induced Destabilization of L-Selectin Rolling Adhesions1 (2007) (7)
- High-frequency generation of altered Mr 70,000 env glycoproteins in N-methyl-N'-nitro-N-nitrosoguanidine-treated murine tumor cells. (1988) (7)
- STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice (2022) (7)
- [The primary structure of a monoclonal IgA-immunoglobulin (IgA Tro.), II. The amino acid sequence of the H-chain, alpha-type, subgroup III; structure of the complete IgA-molecule (author's transl)]. (1975) (7)
- Recent insights into the role of L1CAM in cancer initiation and progression (2020) (7)
- Magnetic resonance imaging of melanoma metastases in a clinical relevant human melanoma xenograft scid mouse model. (2009) (6)
- Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum‐response (2018) (6)
- Endogenous retroviral env genes after N-methyl-N'-nitro-N-nitrosoguanidine treatment of mouse tumor cells: stable DNA amplification and rearrangement. (1989) (6)
- Critical amino acid residues of the alpha4 subunit for alpha4beta7 integrin function. (2001) (6)
- Clonal analysis of H-2 antigen expression by variants of a chemically induced murine tumor. (1981) (6)
- HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in Melanoma (2020) (5)
- Phenotypic and genotypic differences between high- and low-metastatic related tumor lines and the problem of tumor progression and variant generation. (1983) (5)
- Lack of CD24 expression in mice reduces the number of leukocytes in the colon. (2014) (5)
- Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal–maternal interface (2016) (5)
- Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies (2019) (5)
- Elevated L 1 CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma (2010) (5)
- Reduced Placental CD24 in Preterm Preeclampsia Is an Indicator for a Failure of Immune Tolerance (2021) (5)
- The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas (2021) (4)
- Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2 (2022) (4)
- miR-449a Repression Leads to Enhanced NOTCH Signaling in TMPRSS2:ERG Fusion Positive Prostate Cancer Cells (2021) (4)
- Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression (2018) (4)
- The role of L1 in the progression of ovarian carcinomas. (2004) (4)
- [Primary structure of class II human histocompatibility antigens. 1st communication. Amino acid sequence of the N-terminal 198 residues of the beta chain of a HLA-Dw2,2;DR2,2-alloantigen (author's transl)]. (1981) (4)
- Abstract P3-06-08: Ki-67 mRNA as a predictor for response to neoadjuvant chemotherapy in primary breast cancer (2012) (3)
- The Neural Cell Adhesion Molecule N-CAM Enhances Ll-dependent Cell-Cell Interactions (2002) (3)
- L1-CAM is commonly expressed in testicular germ cell tumours (2016) (3)
- CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion (2011) (3)
- L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary (2022) (3)
- Evolutionary Origin of Antibody Specificity (1976) (3)
- DNA Promoter Methylation and ERG regulate the expression of CD24 in prostate cancer. (2021) (3)
- Molecular identification of lectin binding sites differentiating related low and high metastatic murine lymphomas (2005) (2)
- Abstract P3-06-19: Ki-67 mRNA as a predictor for response to neoadjuvant chemotherapy in primary breast cancer (2012) (2)
- Identification and proteomic profiling of biliary exosomes (2015) (2)
- Generation of adhesive tumor variants: Chromosomal changes, reduction in malignancy and increased expression of a distinct membrane glycoprotein (1988) (2)
- Exosomes from human ovarian carcinoma SKOV3 cells are enriched in glycosylated proteins (2010) (2)
- Unexpected H-2 antigen expression by mouse tumor cells, a cautionary note (2004) (2)
- L 1-CAM is commonly expressed in testicular germ cell tumours (2017) (1)
- Perspective – Escape from destruction: how cancer-derived EVs are protected from phagocytosis (2020) (1)
- Genetic determination of antibody specificity (1978) (1)
- Detection of Tumour‐Associated Transplantation Antigens by Syngeneic Cytotoxic T Lymphocytes after Fusion of Tumour Cell Membrane Vesicles to Recipient Cells (1984) (1)
- HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling (2022) (1)
- CD24 controls Src/STAT3 activity in human tumors (2012) (1)
- A Role for Cell Surface Sialic Acid in Liberating Metastatic Tumor Cells from Host Control (1986) (1)
- Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens (2018) (1)
- Modeling Preeclampsia In Vitro: Polymorphic Variants of STOX1-A/B Genes Can Downregulate CD24 in Trophoblast Cell Lines (2022) (1)
- Large international multicenter evaluation of the clinical significance of L1-CAM expression in FIGO stage I, type 1 endometrial cancer. (2011) (1)
- Secretogranin II influences the assembly and function of MHC class I in melanoma (2023) (1)
- Prolongation of rat to mouse islet xenografts with ultraviolet irradiation and antibodies to murine CD2 or CD4 (1990) (1)
- Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens (2013) (1)
- Changes in metastasis formation and distinct cell surface molecules in adhesion variants of a metastatic murine tumor. (1988) (1)
- Good tolerability and limited target-specific tissue distribution of an anti-L1CAM antibody administered to cynomolgus monkey indicates favorable safety profile of L1CAM-targeting therapies. (2018) (0)
- [Primary structure of human class II histocompatibility antigens (HLA-D). I. Isolation, purification and characterization of the HLA-D alpha/beta chain complex from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2, 2;DR2,2;MT1,1;DC1,1;MB1,1]. (1984) (0)
- Cancer by Monoclonal Antibodies or Small Interfering RNA Targeting CD 24 for Treatment of Colorectal and Pancreatic (2008) (0)
- Diagnostic method based on the detection of the L1 adhesion molecule for ovarian tumors and endometrium. (2000) (0)
- 346 POSTER Myofibroblasts and TGF-beta1 induce upregulation of tumoral L1CAM thereby promoting malignant transformation of pancreatic ductal epithelial cells (2008) (0)
- The GPI-Anchored Receptor CD24 Increases Cancer Cell Invasion through Enhanced Contractile Forces (2011) (0)
- Abstract B3: CD24 affects tumor cell properties and cytokine secretion in a STAT3-dependent fashion (2013) (0)
- Treatment of tumors using antibodies specific anti-L1 (2008) (0)
- 172 POSTER The adhesion molecule L1CAM mediates chemoresistance in pancreatic carcinoma cells (2006) (0)
- Erratum: (Journal of Cell Biology (November 12, 2001) 155:4 (661-673)) (2001) (0)
- Role of L1 cell adhesion molecule (L1CAM) in the metastatic cascade: promotion of dissemination, colonization, and metastatic growth (2013) (0)
- SELECTED ORAL COMMUNICATION SESSION, SESSION 62: ENDOMETRIUM, IMPLANTATION AND ENDOMETRIOSIS Wednesday 6 July 2011 10:00 – 11:45 (2011) (0)
- Abstract 3087: CD24 regulates tumor cell behaviour in a c-Src dependent fashion (2012) (0)
- Referee acknowledgement for 2017 (2018) (0)
- [Rule of antibody structure: the primary structure of a human monoclonal IgA1-immunoglobulin (myeloma protein Tro), V. The arrangement of the tryptic peptides and a discussion of the complete primary structure of the H-chain (author's transl)]. (1978) (0)
- Erratum to “Molecular mechanisms of L-selectin-induced co-localization in rafts and shedding” [Biochem. Biophys. Res. Commun. 300 (2003) 563–569] (2003) (0)
- 865 Elevated L1CAM expression mediates malignant transformation and enhances tumourigenicity of pancreatic ductal epithelial cells (2010) (0)
- Cell surface glycoprotein differences between a highly malignant murine tumor line and a plastic-adherent, less malignant variant. (1987) (0)
- Modulations of tumor cell immunogenicity resulting in increase of t cell reactivity (1985) (0)
- ResearchADAM 10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases (2015) (0)
- Overexpression of TMPRSS2:ERG variants activates TGF-β signaling and promotes invasion of prostate cancer cells (2016) (0)
- The molecular and epigenetic function of the signaling molecule CD24 in germ cell tumors and its suitability as a therapeutic target using antibodies and NK-CAR cells (2022) (0)
- A diagnostic method for ovarian and endometrial tumors based on the detection of the L1 adhesion molecule (2000) (0)
- CD24 is an Important Oncogene in the Colon (2011) (0)
- Epidermal growth factor-mediated signaling in ovarian cancer and the role of miR-34a and 6p22 gene amplification-based E2F3a control. (2011) (0)
- Abstract P1-08-07: High tumor CD68 mRNA content (intratumoral macrophages) predicts response to neoadjuvant chemotherapy (2013) (0)
- Predictive value of CD24 ala/val polymorphism for pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer. (2010) (0)
- ' s response to reviews Title : Interaction and uptake of exosomes by ovarian cancer cells (2011) (0)
- , Johannes Ridinger , via Toll-like Receptor Signaling CellsInflammatory Cytokines in Monocytic Body Fluid Exosomes Promote Secretion of Signal Transduction (2013) (0)
- L1CAM-dependent NFκB activation upregulates fascin expression and augments tumor cell invasion and motility (2007) (0)
- Abstract 204: Single-molecule localization microscopy analysis of a cancer metastasis-specific miRNA on the nanoscale (2015) (0)
- S8.6 Nectadrin (heat-stable antigen) glycoforms as ligand for mouse P-selectin (1993) (0)
- Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer (2016) (0)
- Change in metastasis and organotropism of mouse lymphoma variants associated with changes in expression of adhesion molecules and chemotactic responsiveness (1991) (0)
- Regulation of the EGFR-E2F3a axis by the interferon regulatory factor (IRFs) and by promoter methylation of miR-34a in ovarian cancer. (2016) (0)
- Abstract 4723: Soluble L1-CAM in the ascites is a prognostic marker in ovarian cancer (2011) (0)
- Abstract 2324: The cell adhesion molecule L1-CAM is expressed in non-small cell lung cancer and is a prognostic marker for progression free survival (2010) (0)
- Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens (2018) (0)
- Abstract B42: The cell adhesion molecule, L1CAM, is important for the dissemination and metastasis of fallopian tube precursor lesions (2018) (0)
- L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor (2014) (0)
- Murine CD2 mediates cellular immune responses in vivo. (1991) (0)
- Treatment of tumors using anti-L1 specific. (2008) (0)
- Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer (2014) (0)
- L1-Targeted Cu-67-radioimmunotherapy in combination with immunotherapy for treatment of ovarian cancer metastases (2006) (0)
- [Primary structure of human class II histocompatibility antigens (HLA-D). II. Separation of alpha from beta-chains of HLA-D from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2,2;MT1,1;DC1,1;MB1,1), and characterization of the isolated chain]. (1984) (0)
- From Retrograde Menstruation to Endometriosis – A Possible Pathophysiological Role of L1, a Cell Adhesion and Migration Protein (2005) (0)
- Additional file 1: of Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer (2017) (0)
- Acknowledgement to reviewers (2004) (0)
- Abstract C59: Antibody targeting of CD24 efficiently retards growth of experimental carcinomas. (2011) (0)
- Late abstracts 186–187 (2005) (0)
- Mo1802 Role of CD24 in the Development of DSS-Induced Murine Experimental Colitis (2012) (0)
- Involves Two Distinct Mechanisms Dendritic Cells upon CD4+ T Cell Priming Transfer of T Cell Surface Molecules to (2013) (0)
- Differentially expressed genes in prostate cancer — identification of CD24 as a new prognostic marker (2004) (0)
- The r Integrin Chain Is a Ligand for r and o ~ 4 B 1 By (2003) (0)
- [Rule of antibody structure: the primary structure of a human monoclonal IgA1-immunoglobulin (Myeloma protein Tro). IV. Isolation and characterization of the chymotryptic peptides of the H-chain (author's transl)]. (1978) (0)
- Myeloid-derived suppressor cells and tumor escape from immune surveillance (2016) (0)
- Highly Procoagulant Extracellular Vesicles in Amniotic Fluid (2016) (0)
- Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer (2017) (0)
- 693 A Novel Anti-CD24-Toxin Immunoconjugate for Targeted Therapy of Colorectal and Pancreatic Cancers (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Peter Altevogt?
Peter Altevogt is affiliated with the following schools:
